Cargando…

Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study

OBJECTIVE: We aim to evaluate 3-year effects of ocrelizumab (humanized anti-CD20 monoclonal antibody for the treatment of multiple sclerosis (MS)) on lymphocytes, neutrophils and immunoglobulins: (1) when compared with pre-infusion assessment; (2) over the course of treatment; and (3) possible clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capasso, Nicola, Palladino, Raffaele, Cerbone, Vincenza, Spiezia, Antonio Luca, Covelli, Bianca, Fiore, Antonia, Lanzillo, Roberta, Carotenuto, Antonio, Petracca, Maria, Stanziola, Lucia, Scalia, Giulia, Brescia Morra, Vincenzo, Moccia, Marcello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813008/ https://www.ncbi.nlm.nih.gov/pubmed/36048265 http://dx.doi.org/10.1007/s00415-022-11350-1

Ejemplares similares

Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy
por: Moccia, Marcello, et al.
Publicado: (2022)

Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study
por: Lanzillo, Roberta, et al.
Publicado: (2022)

Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015
por: Moccia, Marcello, et al.
Publicado: (2017)

Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)
por: Moccia, Marcello, et al.
Publicado: (2020)

Single-Center 8-Years Clinical Follow-Up of Cladribine-Treated Patients From Phase 2 and 3 Trials
por: Moccia, Marcello, et al.
Publicado: (2020)

Neuroimaging Correlates of Cognitive Dysfunction in Adults with Multiple Sclerosis
por: Petracca, Maria, et al.
Publicado: (2021)

Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis
por: Caliendo, Daniele, et al.
Publicado: (2023)

Interferon beta for the treatment of multiple sclerosis in the Campania Region of Italy: Merging the real-life to routinely collected healthcare data
por: Moccia, Marcello, et al.
Publicado: (2021)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice
por: De Angelis, Marcello, et al.
Publicado: (2020)

Retinal and Choriocapillary Vascular Changes in Early Stages of Multiple Sclerosis: A Prospective Study
por: Montorio, Daniela, et al.
Publicado: (2021)

AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature
por: Spiezia, Antonio Luca, et al.
Publicado: (2022)

A Retrospective Exploratory Analysis on Cardiovascular Risk and Cognitive Dysfunction in Multiple Sclerosis
por: Reia, Antonio, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
por: Capasso, Nicola, et al.
Publicado: (2020)

Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg
por: Capasso, Nicola, et al.
Publicado: (2021)

Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review
por: De Angelis, Marcello, et al.
Publicado: (2021)

Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Sample Size for Oxidative Stress and Inflammation When Treating Multiple Sclerosis with Interferon-β1a and Coenzyme Q10
por: Moccia, Marcello, et al.
Publicado: (2019)

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2019)

Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience
por: Rosa, Laura, et al.
Publicado: (2022)

COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak
por: Buonomo, Antonio, et al.
Publicado: (2020)

Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis
por: Cennamo, Gilda, et al.
Publicado: (2020)

Associations between cognitive impairment at onset and disability accrual in young people with multiple sclerosis
por: Carotenuto, Antonio, et al.
Publicado: (2019)

Multiple Sclerosis in the Campania Region (South Italy): Algorithm Validation and 2015–2017 Prevalence
por: Moccia, Marcello, et al.
Publicado: (2020)

Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions
por: Vola, Elena Augusta, et al.
Publicado: (2021)

Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study
por: Rosa, Laura, et al.
Publicado: (2022)

A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2022)

Corrigendum: A two-year longitudinal study of retinal vascular impairment in patients with amnestic mild cognitive impairment
por: Criscuolo, Chiara, et al.
Publicado: (2023)

Determinants of early working impairments in multiple sclerosis
por: Moccia, Marcello, et al.
Publicado: (2022)

Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study
por: Affinito, Giuseppina, et al.
Publicado: (2023)

Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
por: Moccia, Marcello, et al.
Publicado: (2022)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level
por: Lanzillo, Roberta, et al.
Publicado: (2014)

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery
por: Moccia, Marcello, et al.
Publicado: (2019)

Correlation analysis between foveal avascular zone and near peripheral retinal hypoperfusion in multiple sclerosis: a wide field optical coherence tomography angiography study
por: Montorio, Daniela, et al.
Publicado: (2022)

Cognitive trajectories in multiple sclerosis: a long-term follow-up study
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Correction to: Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin
por: Pontillo, Giuseppe, et al.
Publicado: (2022)

Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin
por: Pontillo, Giuseppe, et al.
Publicado: (2022)

Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Assessment of retinal vascular network in amnestic mild cognitive impairment by optical coherence tomography angiography
por: Criscuolo, Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gtmqupkmkj8ils70dcp9m8ictt